Related Experiment Video
Updated: Dec 7, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Sequelae of COVID-19 in Hospitalized Children: A 4-Months Follow-Up
Marco Denina1, Giulia Pruccoli1, Carlo Scolfaro1
1From the Department of Pediatrics, Infectious Diseases Unit.
Insights
Sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children are not well understood. A 4-month follow-up of 25 children hospitalized with COVID-19 found rare mid-term sequelae, suggesting a favorable prognosis.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- The long-term effects of SARS-CoV-2 infection in pediatric populations remain largely unknown.
- Understanding post-COVID-19 conditions in children is crucial for clinical management and public health strategies.
Purpose of the Study:
- To investigate the mid-term clinical, laboratory, and imaging sequelae in children previously hospitalized with COVID-19.
- To assess the frequency and nature of any persistent symptoms or complications.
Main Methods:
- A cohort of 25 children hospitalized for COVID-19 was prospectively followed for 4 months.
- Evaluations included clinical assessments, laboratory tests, and lung ultrasound imaging.
- Data analysis focused on identifying any residual health issues.
Main Results:
- Mid-term sequelae were infrequently observed in the studied cohort of children.
- The majority of children showed no significant clinical, laboratory, or lung ultrasound abnormalities at follow-up.
- This suggests a generally good recovery trajectory for most pediatric COVID-19 patients.
Conclusions:
- Hospitalized children with COVID-19 appear to have a low incidence of mid-term sequelae.
- Further research is warranted to confirm these findings in larger, diverse pediatric cohorts.
- The study provides preliminary evidence for a favorable prognosis following severe acute respiratory syndrome coronavirus 2 infection in children.
Abstract:
Little is known about the sequelae of SARS-CoV-2 infection in children. In a COVID-19 dedicated clinic, we followed-up for 4 months 25 children previously hospitalized for COVID-19, performing clinical, laboratory, and lung ultrasound evaluation. Mid-term sequelae were rarely observed in our COVID-19 children's cohort.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Asthma-III: Symptoms and Complications
Classification of Asthma

